42 employees
OncoSec is a biotechnology company focusing on designing and developing gene therapies, therapeutics, and medical approaches.
2011
$15M
from 2 investors over 2 rounds
OncoSec raised $15M on September 4, 2018
Investors: ALPHACHIPS Corp
OncoSec raised $163K on October 27, 2014
Investors: National Institutes of Health